Entsar Eladl

Role of CD47 in Hematological Malignancies

Hong Chang, Wenming Chen, N. Rastgoo, 2020, Journal of Hematology & Oncology.

Antiangiogenic activity of vitexicarpine in experimentally induced hepatocellular carcinoma: Impact on vascular endothelial growth factor pathway

Noha Abdel-Rahman, M. El-Shishtawy, Entsar Eladl, 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Molecular characterization of AML‐MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC‐defining criteria, TP53 allelic state, or TP53 variant allele frequency

M. Minden, E. Atenafu, J. Capo-Chichi, 2022, Cancer medicine.

NPM1-mutated AML-MRC diagnosed on the basis of history of MDS or MDS/MPN frequently harbours secondary-type mutations and confers inferior outcome compared to AML with mutated NPM1.

M. Minden, E. Atenafu, J. Capo-Chichi, 2022, Leukemia research.

Prognostic Value of BRAF, Programmed Cell Death 1 (PD1), and PD Ligand 1 (PDL1) Protein Expression in Colon Adenocarcinoma

Afaf T. Ibrahiem, M. Fawzy, E. Toraih, 2023, Diagnostics.

Molecular genetic characterization of Philadelphia chromosome-positive acute myeloid leukemia.

J. Capo-Chichi, Qianghua Zhou, Dennis (Dong Hwan) Kim, 2022, Leukemia research.

AML with CEBPA mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blasts.

Y. W. Yeung, M. Minden, E. Atenafu, 2023, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

Antiangiogenic activity of vitexicarpine in experimentally induced hepatocellular carcinoma: Impact on vascular endothelial growth factor pathway

Noha Abdel-Rahman, M. El-Shishtawy, Entsar Eladl, 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.